-
Featured News /
European Patient Innovation Summit publishes a position paper on Digital Health from a Patient Perspective with recommendations on digital health.
-
Featured News /
On April 9, 2019 Alcon becomes a separately traded company. Novartis and Alcon are now positioned to capitalize on significant growth opportunities and focus resources on their respective businesses and strategic priorities.
-
Featured News /
Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.
-
Featured News /
From January 13-16 2020, Novartis attended the J.P Morgan Healthcare Conference in San Francisco.
-
Story /The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.
-
Story /A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines
-
Story /Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.
-
Featured News /
-
Featured News /
-
Story /Technology used to tag friends on social media could change the way drug discovery is done.